131 related articles for article (PubMed ID: 18480841)
1. Induction of T-cell responses against cutaneous T-cell lymphomas ex vivo by autologous dendritic cells transfected with amplified tumor mRNA.
Ni X; Richmond HM; Liao XM; Decker WK; Shiue LH; Shpall EJ; Duvic M
J Invest Dermatol; 2008 Nov; 128(11):2631-2639. PubMed ID: 18480841
[TBL] [Abstract][Full Text] [Related]
2. EPHA4 is overexpressed but not functionally active in Sézary syndrome.
Hameetman L; van der Fits L; Zoutman WH; Out-Luiting JJ; Siegal G; de Esch IJ; Vermeer MH; Tensen CP
Oncotarget; 2015 Oct; 6(31):31868-76. PubMed ID: 26376612
[TBL] [Abstract][Full Text] [Related]
3. IL-21 enhances antitumor responses without stimulating proliferation of malignant T cells of patients with Sézary syndrome.
Yoon JS; Newton SM; Wysocka M; Troxel AB; Hess SD; Richardson SK; Lin JH; Benoit BM; Kasprzycka M; Wasik MA; Rook AH
J Invest Dermatol; 2008 Feb; 128(2):473-80. PubMed ID: 17713571
[TBL] [Abstract][Full Text] [Related]
4. Tumour-specific cytotoxic T lymphocyte activity in Th2-type Sézary syndrome: its enhancement by interferon-gamma (IFN-gamma) and IL-12 and fluctuations in association with disease activity.
Seo N; Tokura Y; Matsumoto K; Furukawa F; Takigawa M
Clin Exp Immunol; 1998 Jun; 112(3):403-9. PubMed ID: 9649208
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of lymphocyte interleukin-12 receptor expression in Sézary syndrome.
Zaki MH; Shane RB; Geng Y; Showe LC; Everetts SE; Presky DH; Wysocka M; Moore JS; Rook AH
J Invest Dermatol; 2001 Jul; 117(1):119-27. PubMed ID: 11442758
[TBL] [Abstract][Full Text] [Related]
6. [Generation of T cell-mediated antitumor response in vitro by autologous dendritic cells pulsed with tumor lysates in patients with non-small cell lung cancer].
You J; Yu JP; Ren XB; Wang CL; Zhang P; Zhang XZ
Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):333-6. PubMed ID: 15312341
[TBL] [Abstract][Full Text] [Related]
7. mu-Opioid receptor is induced by IL-13 within lymph nodes from patients with Sézary syndrome.
Bénard A; Cavaillès P; Boué J; Chapey E; Bayry J; Blanpied C; Meyer N; Lamant L; Kaveri SV; Brousset P; Dietrich G
J Invest Dermatol; 2010 May; 130(5):1337-44. PubMed ID: 20107485
[TBL] [Abstract][Full Text] [Related]
8. A simple immunomonitoring procedure for mRNA-loaded dendritic cell therapy.
Hiura M; Ueno K; Suehiro Y; Hazama S; Oka M; Imai K; Hinoda Y
Tumour Biol; 2007; 28(6):350-7. PubMed ID: 18391552
[TBL] [Abstract][Full Text] [Related]
9. Sézary syndrome patients demonstrate a defect in dendritic cell populations: effects of CD40 ligand and treatment with GM-CSF on dendritic cell numbers and the production of cytokines.
Wysocka M; Zaki MH; French LE; Chehimi J; Shapiro M; Everetts SE; McGinnis KS; Montaner L; Rook AH
Blood; 2002 Nov; 100(9):3287-94. PubMed ID: 12384429
[TBL] [Abstract][Full Text] [Related]
10. IL-12 reverses cytokine and immune abnormalities in Sezary syndrome.
Rook AH; Kubin M; Cassin M; Vonderheid EC; Vowels BR; Wolfe JT; Wolf SF; Singh A; Trinchieri G; Lessin SR
J Immunol; 1995 Feb; 154(3):1491-8. PubMed ID: 7822812
[TBL] [Abstract][Full Text] [Related]
11. Abnormal cytokine expression in Sézary and adult T-cell leukemia cells correlates with the functional diversity between these T-cell malignancies.
Tendler CL; Burton JD; Jaffe J; Danielpour D; Charley M; McCoy JP; Pittelkow MR; Waldmann TA
Cancer Res; 1994 Aug; 54(16):4430-5. PubMed ID: 7913876
[TBL] [Abstract][Full Text] [Related]
12. The Role of Tumor Microenvironment in the Pathogenesis of Sézary Syndrome.
Miyashiro D; Souza BCE; Torrealba MP; Manfrere KCG; Sato MN; Sanches JA
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055124
[TBL] [Abstract][Full Text] [Related]
13. Isolation of tumor-specific cytotoxic CD4+ and CD4+CD8dim+ T-cell clones infiltrating a cutaneous T-cell lymphoma.
Bagot M; Echchakir H; Mami-Chouaib F; Delfau-Larue MH; Charue D; Bernheim A; Chouaib S; Boumsell L; Bensussan A
Blood; 1998 Jun; 91(11):4331-41. PubMed ID: 9596682
[TBL] [Abstract][Full Text] [Related]
14. Aberrant cytokine production by Sezary syndrome patients: cytokine secretion pattern resembles murine Th2 cells.
Vowels BR; Cassin M; Vonderheid EC; Rook AH
J Invest Dermatol; 1992 Jul; 99(1):90-4. PubMed ID: 1607682
[TBL] [Abstract][Full Text] [Related]
15. An autologous therapeutic dendritic cell vaccine transfected with total lung carcinoma RNA stimulates cytotoxic T lymphocyte responses against non-small cell lung cancer.
Wang K; Zhou Q; Guo AL; Xu CR; An SJ; Wu YL
Immunol Invest; 2009; 38(7):665-80. PubMed ID: 19811429
[TBL] [Abstract][Full Text] [Related]
16. Langerhans cells from human cutaneous squamous cell carcinoma induce strong type 1 immunity.
Fujita H; Suárez-Fariñas M; Mitsui H; Gonzalez J; Bluth MJ; Zhang S; Felsen D; Krueger JG; Carucci JA
J Invest Dermatol; 2012 Jun; 132(6):1645-55. PubMed ID: 22402444
[TBL] [Abstract][Full Text] [Related]
17. Measurement of CD8+ and CD4+ T Cell Frequencies Specific for EBV LMP1 and LMP2a Using mRNA-Transfected DCs.
Sohn DH; Sohn HJ; Lee HJ; Lee SD; Kim S; Hyun SJ; Cho HI; Cho SG; Lee SK; Kim TG
PLoS One; 2015; 10(5):e0127899. PubMed ID: 26023769
[TBL] [Abstract][Full Text] [Related]
18. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
[TBL] [Abstract][Full Text] [Related]
19. FOXP3+CD25- tumor cells with regulatory function in Sézary syndrome.
Heid JB; Schmidt A; Oberle N; Goerdt S; Krammer PH; Suri-Payer E; Klemke CD
J Invest Dermatol; 2009 Dec; 129(12):2875-85. PubMed ID: 19626037
[TBL] [Abstract][Full Text] [Related]
20. Induction of cytotoxic T lymphocytes primed with tumor RNA-loaded dendritic cells in esophageal squamous cell carcinoma: preliminary step for DC vaccine design.
Gholamin M; Moaven O; Farshchian M; Mahmoudi M; Sankian M; Memar B; Forghani MN; Malekzadeh R; Rajabi-Mashhadi MT; Abbaszadegan MR
BMC Cancer; 2010 Jun; 10():261. PubMed ID: 20525404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
